新股暗盘 | 健世科技-B(9877.HK)暗盘段收涨6.47%

格隆汇2022-10-07

格隆汇10月7日丨健世科技-B(9877.HK)暗盘段收涨6.47%报29.6港元，总市值123亿港元。健世科技致力于开发用于治疗结构性心脏病(包括三尖瓣疾病、主动脉瓣疾病、二尖瓣疾病及心力衰竭)的介入产品，是具备结构性心脏病完整产品管线布局的平台型公司。其核心产品之一LuX-Valve经导管三尖瓣置换系统预计是全球首批获准上市的三尖瓣置换产品之一，由健世科技独立自主研发，已在全球范围内成功为超...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2273440368?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2022-10-07 19:01","share_image_url":"https://static.laohu8.com/6b8fa6424aebe95f6781d04ef17a1852","id":"2273440368","market":"hk","top_or_hot":-1,"title":"新股暗盘 | 健世科技-B(9877.HK)暗盘段收涨6.47%","media":"格隆汇","content":"<div>\n<p>格隆汇10月7日丨健世科技-B(9877.HK)暗盘段收涨6.47%报29.6港元，总市值123亿港元。健世科技致力于开发用于治疗结构性心脏病(包括三尖瓣疾病、主动脉瓣疾病、二尖瓣疾病及心力衰竭)的介入产品，是具备结构性心脏病完整产品管线布局的平台型公司。其核心产品之一LuX-Valve经导管三尖瓣置换系统预计是全球首批获准上市的三尖瓣置换产品之一，由健世科技独立自主研发，已在全球范围内成功为超...</p>\n\n<a href=\"http://www.gelonghui.com/rss/live/live.xml\">网页链接</a>\n\n</div>\n","source":"live_gelonghui","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>新股暗盘 | 健世科技-B(9877.HK)暗盘段收涨6.47%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n新股暗盘 | 健世科技-B(9877.HK)暗盘段收涨6.47%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-10-07 19:01 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.gelonghui.com/rss/live/live.xml><strong>格隆汇</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>格隆汇10月7日丨健世科技-B(9877.HK)暗盘段收涨6.47%报29.6港元，总市值123亿港元。健世科技致力于开发用于治疗结构性心脏病(包括三尖瓣疾病、主动脉瓣疾病、二尖瓣疾病及心力衰竭)的介入产品，是具备结构性心脏病完整产品管线布局的平台型公司。其核心产品之一LuX-Valve经导管三尖瓣置换系统预计是全球首批获准上市的三尖瓣置换产品之一，由健世科技独立自主研发，已在全球范围内成功为超...</p>\n\n<a href=\"http://www.gelonghui.com/rss/live/live.xml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09877","symbol_name":"健世科技-B","start_time":0,"source_url":"http://www.gelonghui.com/rss/live/live.xml","article_id":"2273440368","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2273440368","pubTimestamp":1665140461,"sourceInfo":{"source_id":"live_gelonghui","name":"格隆汇"},"weMediaInfo":null,"summary":"格隆汇10月7日丨健世科技-B(9877.HK)暗盘段收涨6.47%报29.6港元，总市值123亿港元。健世科技致力于开发用于治疗结构性心脏病(包括三尖瓣疾病、主动脉瓣疾病、二尖瓣疾病及心力衰竭)的介","collect":0,"end_time":0,"defaultTopTitle":"gelonghui.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"09877":"健世科技-B"},"translate_title":"The dark segment of new shares Jianshi Technology-B (9877. HK) closed up 6.47%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09877":1},"content_text":"格隆汇10月7日丨健世科技-B(9877.HK)暗盘段收涨6.47%报29.6港元，总市值123亿港元。健世科技致力于开发用于治疗结构性心脏病(包括三尖瓣疾病、主动脉瓣疾病、二尖瓣疾病及心力衰竭)的介入产品，是具备结构性心脏病完整产品管线布局的平台型公司。其核心产品之一LuX-Valve经导管三尖瓣置换系统预计是全球首批获准上市的三尖瓣置换产品之一，由健世科技独立自主研发，已在全球范围内成功为超300名三尖瓣反流患者完成三尖瓣微创置换手术，在中国及北美、欧洲等发达国家地区均受到高度认可。三尖瓣疾病发病率高，全球范围内尚无有效治疗方案，市场潜力巨大。沙利文预计中国的经导管三尖瓣介入手术到2030年将达到200900例，2023年至2025年的复合年增长率为232.2%，2025年至2030年的复合年增长率为97.1%。","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2273440368"}